Flotek raises 2026 revenue guidance to $360-370M, Adjusted EBITDA to $50-54M
Flotek Industries Inc. raised its 2026 revenue guidance to $360-370M from $340-350M and adjusted EBITDA guidance to $50-54M. Q2 revenue was $99.4M, up 70% YoY, with adjusted EBITDA at $16.8M, up 109% YoY. International chemistry sales surged, with Q2 revenue at $10.6M and potential for 2H26 sales to exceed $40M. The company updated its corporate presentation for the Lake Street investor conference.
How this was made
The 30-second read
Why it matters
The guidance lift signals stronger growth trajectory, likely prompting analysts to revise forecasts.
Market read
Guidance update is a primary catalyst for FTK's stock, with potential spill‑over to the broader chemicals sector.
What to watch
Potential supply‑chain constraints or raw‑material cost volatility not addressed.
Background
Flotek Industries Inc. (FTK) filed an 8‑K on Sep 9 2026 announcing updated 2026 guidance and recent Q2 results.
Ticker impact
Flotek raised its 2026 revenue guidance to $360‑370M and Adjusted EBITDA to $50‑54M in a fresh SEC 8‑K filing.
Potential price appreciation as investors re‑price higher earnings expectations.
The company disclosed a material increase in both revenue and EBITDA guidance, a primary catalyst for valuation.
Market effects
Higher guidance may lift peers in specialty chemicals and industrial solvents.
Positive for U.S. industrial sector sentiment.
Limited to investors tracking mid‑cap industrials.
Counterpoint
Guidance could be overly optimistic if demand peaks are temporary.
Key entities
- CompanyFlotek Industries Inc.
Specialty chemicals producer.
